Abbrea Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.01M | Sell |
1,820
-212
| -10% | -$117K | 0.13% | 117 |
|
|
2024
Q1 | $1.18M | Buy |
2,032
+70
| +4% | +$40.7K | 0.16% | 113 |
|
|
2023
Q4 | $1.04M | Sell |
1,962
-47
| -2% | -$25K | 0.15% | 116 |
|
|
2023
Q3 | $1.02M | Buy |
2,009
+64
| +3% | +$32.4K | 0.16% | 108 |
|
|
2023
Q2 | $1.02M | Buy |
1,945
+432
| +29% | +$225K | 0.16% | 117 |
|
|
2023
Q1 | $873K | Buy |
1,513
+110
| +8% | +$63.5K | 0.15% | 118 |
|
|
2022
Q4 | $773K | Sell |
1,403
-105
| -7% | -$57.9K | 0.14% | 121 |
|
|
2022
Q3 | $765K | Sell |
1,508
-202
| -12% | -$102K | 0.14% | 119 |
|
|
2022
Q2 | $930K | Buy |
1,710
+79
| +5% | +$43K | 0.15% | 115 |
|
|
2022
Q1 | $964K | Sell |
1,631
-350
| -18% | -$207K | 0.14% | 118 |
|
|
2021
Q4 | $1.32M | Buy |
1,981
+316
| +19% | +$211K | 0.18% | 99 |
|
|
2021
Q3 | $952K | Buy |
1,665
+554
| +50% | +$317K | 0.14% | 114 |
|
|
2021
Q2 | $561K | Buy |
1,111
+590
| +113% | +$298K | 0.08% | 159 |
|
|
2021
Q1 | $238K | Buy |
+521
| New | +$238K | 0.04% | 212 |
|